Marker Therapeutics (MRKR) Cash from Operations (2010 - 2026)
Marker Therapeutics (MRKR) posted Cash from Operations of -$3.72 million for Q2 2026, compared with -$1.88 million a year earlier.
Marker Therapeutics (MRKR) Cash from Operations (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Operations at Marker Therapeutics was -$9.76 million; for FY2025, it was -$12.01 million.
- In prior years, Marker Therapeutics' Cash from Operations was -$10.91 million in FY2024, -$16.44 million in FY2023, -$26.97 million in FY2022 and -$27.28 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Cash from Operations since Q1 2025.
- According to Business Quant data, Cash from Operations for the three prior quarters was -$1.4 million (Q1 2026), -$1.9 million (Q4 2025) and -$2.74 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | -3.72 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.72 Mn |
| Mar 31, 2026 | -1.40 Mn |
| Dec 31, 2025 | -1.90 Mn |
| Sep 30, 2025 | -2.74 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | -5.50 Mn |
| Dec 31, 2024 | -4.70 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -3.57 Mn |
| Mar 31, 2024 | -3.84 Mn |
| Dec 31, 2023 | -2.37 Mn |
| Sep 30, 2023 | -1.13 Mn |
| Jun 30, 2023 | -7.06 Mn |
| Mar 31, 2023 | -5.89 Mn |
| Dec 31, 2022 | -6.31 Mn |
| Sep 30, 2022 | -7.65 Mn |
| Jun 30, 2022 | -794,706.00 |
| Mar 31, 2022 | -12.23 Mn |
| Dec 31, 2021 | -4.86 Mn |
| Sep 30, 2021 | -7.54 Mn |
Marker Therapeutics Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=MRKR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();